Clinical Trials
256 trialsEvolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)
UNICANCER
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Hoffmann-La Roche
Bio-lung
University Hospital, Lille
LUNG-ROLL
AstraZeneca
POPPY
University of Sydney
VENTURE
University of Sydney
Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
AstraZeneca
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
Washington University School of Medicine
MYLUNG
US Oncology Research
ALCG-01
Gazi University
DeniLA
AstraZeneca
3D Virtual Resection for Predicting Lung Function in VATS
National Taiwan University Hospital
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
LONGEVITI
University of Alberta
SHERLOCK
University Health Network, Toronto
NYULCBC
NYU Langone Health
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
VICTORY 2
Portsmouth Hospitals NHS Trust
4D-MRI for Precision Medicine
University of Virginia
iCaRe2
University of Nebraska
Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer
University Health Network, Toronto
Evaluation for NCI Surgery Branch Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
National Institutes of Health Clinical Center (CC)
OMAE
Groupe Francais De Pneumo-Cancerologie
Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
Beijing Chao Yang Hospital
Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation
University Medical Center Groningen
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
Vanderbilt-Ingram Cancer Center
LUNGEVITY
Groupe Francais De Pneumo-Cancerologie
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
LDCT
Southern Illinois University
Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques
Second Affiliated Hospital, School of Medicine, Zhejiang University
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer
University of Texas Southwestern Medical Center
NSCLC Liquid Biopsies and Exhaled VOC
St. Joseph's Healthcare Hamilton
Collection of Blood From Patients With Cancer
National Institutes of Health Clinical Center (CC)
AB1MALTISC-UK
Creo Medical Limited
Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
The University of Texas Health Science Center at San Antonio
Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes
M.D. Anderson Cancer Center
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Institutes of Health Clinical Center (CC)
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
Everest Detection, Inc.
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
National Institutes of Health Clinical Center (CC)
LARCS
Intuitive Surgical
GALENOS 1
Fondazione del Piemonte per l'Oncologia
IKF-ReWoLuTe
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
ASAP
Avera McKennan Hospital & University Health Center
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
European Real-World Registry for Use of the Ion Endoluminal System
Intuitive Surgical
CASCADE
AstraZeneca
LISTENING
Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares